No Data
Zhejiang Yongtai Technology Co., (002326.SZ): A wholly-owned subsidiary has obtained the Pharmaceutical registration certificate for Fumaric Acid Vonoprazan Tablets.
On March 14, Glonghui reported that Zhejiang Yongtai Technology Co., (002326.SZ) announced that its wholly-owned subsidiary Zhejiang Yongtai Pharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for fumagillin vornolazone tablets. Fumagillin vornolazone tablets are potassium ion competitive acid blockers (P-CAB), whose mechanism of action involves blocking the K+ channel of H+/K+-ATPase, competitively blocking the binding of K+ to the enzyme, allowing it to stay in the gastric wall cells for a long time, thus quickly inhibiting gastric acid secretion. It is used to treat gastric acid-related diseases, including reflux esophagitis (RE),
Zhejiang Yongtai Technology Co. (002326.SZ): Currently, a vertically integrated Industry Chain layout has been formed in the field of Lithium Battery materials, ranging from lithium salt raw materials, lithium salts, additives to Electrolyte.
On March 12, Gelonghui reported that Zhejiang Yongtai Technology Co . (002326.SZ) recently stated in investor relations activities that the company has currently established a vertically integrated Industry Chain layout in the field of Lithium Battery materials, ranging from lithium salt raw materials, lithium salts, additives to Electrolyte. The project aims to significantly improve the cycle life of lithium-ion batteries through the development of New Materials and new mechanisms, promote the green sustainable development of the Lithium Battery Industry, and enhance the efficient utilization of resources. The cooperation within this project helps strengthen the company’s deep technological reserves, enhances the core momentum in the field of lithium battery materials, and lays a solid foundation for sustainable development in the company's Global Strategy growth. However, technological development requires.
Zhejiang Yongtai Technology Co ., (002326.SZ): Fluorinated liquid products can be used in the semiconductor manufacturing industry.
On March 12, Gelonghui reported that Zhejiang Yongtai Technology Co. (002326.SZ) recently stated during an investor relations event that the company's fluorinated liquid products can be used in the production and manufacturing of Semiconductors, as well as for immersion Datacenter cooling and Thermal Management of energy storage Batteries. The company currently has relatively mature industrialization conditions and is actively promoting related product development, process verification, and market promotion to ensure that once market conditions are ripe, it can quickly respond to customer demands and achieve large-scale production and supply. This Business is still in its early development stage and occupies a small proportion within the company's overall operations.
Subdued Growth No Barrier To Zhejiang Yongtai Technology Co.,Ltd. (SZSE:002326) With Shares Advancing 32%
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
The Securities Regulatory Commission has approved Kent Catalysts' IPO registration on the Main Board of the Shanghai Stock Exchange.
On January 24, the China Securities Regulatory Commission released the "Reply on Approving the Initial Public Offering Stock Registration of Kent Catalytic Materials Co., Ltd." It is reported that Kent Catalytic plans to list on the Main Board of the Shanghai Stock Exchange, with Sinolink as the sponsor for the IPO, aiming to raise 0.499 billion yuan.
We Think Zhejiang Yongtai TechnologyLtd (SZSE:002326) Has A Fair Chunk Of Debt
